Helius Medical Technologies Inc
NASDAQ:HSDT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Helius Medical Technologies Inc
NASDAQ:HSDT
|
US |
|
Indus Towers Ltd
NSE:INDUSTOWER
|
IN |
|
B
|
Boombit SA
WSE:BBT
|
PL |
|
B
|
Befesa SA
DUS:BFSA
|
LU |
|
Eversource Energy
NYSE:ES
|
US |
|
Nick Scali Ltd
F:NJN
|
AU |
|
Pop Mart International Group Ltd
OTC:POPMF
|
CN |
|
LS Electric Co Ltd
KRX:010120
|
KR |
|
P
|
Poly Culture Group Corp Ltd
F:0P4
|
CN |
|
Abb Ltd
LSE:0NX2
|
CH |
|
Arca Continental SAB de CV
OTC:EMBVF
|
MX |
|
Siemens Ltd
BSE:500550
|
IN |
|
Waste Management Inc
NYSE:WM
|
US |
|
Innovative Solutions and Support Inc
NASDAQ:ISSC
|
US |
|
V
|
Veidekke ASA
OSE:VEI
|
NO |
|
A
|
Appfolio Inc
F:4P0
|
US |
|
United States Steel Corp
NYSE:X
|
US |
|
M
|
Mitsubishi Corp
XMUN:MBI
|
JP |
Wall St Price Targets
HSDT Price Targets Summary
Helius Medical Technologies Inc
According to Wall Street analysts, the average 1-year price target for
HSDT is 3.57 USD with a low forecast of 3.03 USD and a high forecast of 4.2 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HSDT's stock price target?
Price Target
3.57
USD
According to Wall Street analysts, the average 1-year price target for
HSDT is 3.57 USD with a low forecast of 3.03 USD and a high forecast of 4.2 USD.
What is the Revenue forecast for Helius Medical Technologies Inc?
Projected CAGR
42%
The compound annual growth rate for Revenue over the next 3 years is 42%.
What is the Gross Profit forecast for Helius Medical Technologies Inc?
Projected CAGR
46%
The compound annual growth rate for Gross Profit over the next 3 years is 46%.